Menu
Washingtoner
  • Home
  • Boeing
  • Daryl Guberman
  • Health
  • Aerospace
  • Technology
  • Business
  • ANSI-ANAB
  • Non-profit
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • Spokane AI Expert Adam Chronister to Discuss Authority Engineering at AI Roundtable Event
  • Olga Torres Earns Repeat Recognition as a Top 2026 CFIUS Advisor
  • Spokane: Traffic Impacts Starting Monday, May 4th
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • HRC Fertility Celebrates Beverly Hills Grand Opening, Spotlighting Fertility Care as Women's Health Month Begins
  • HRC Fertility's Dr. Christo G. Zouves Appointed to San Mateo County Medical Association Board of Directors
  • HealthBook+ and Stonebrook Risk Solutions Partner to Bring Predictive Intelligence to Healthcare Risk
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • Tacoma City Council Reaffirms Commitment to Immigrants and Refugees, Supports Ongoing State and Federal Advocacy

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Spokane: Council Approves Updates to Mobile Food Truck Regulations
  • Federal Way Murder Suspect Taken into Custody in Spokane
  • BTR: i2 Group Launches i2 Amplify, a Community Platform for Intelligence Professionals Worldwide
  • L.A. Watts Summer Games Announces Free Pelé Tribute Event at Magic Johnson Park
  • Public Hearing Regarding 2026 Amendment to One Tacoma Comprehensive Plan and Land Use Regulatory Code on May 19; Information Session on May 9
  • SUMOFIBER Fuels Explosive Growth With netElastic vBNG
  • NRx Pharmaceuticals (N A S D A Q: NRXP) Accelerates Into National Spotlight as Manufacturing Launch, Federal Policy & AI-Driven Breakthroughs Converge
  • Expanding Into High-Margin Battery Recycling With Black Mass Strategy plus Scaling AI Infrastructure & Global Supply Chain Platform: N A S D A Q: MWYN
  • Long-Distance Couples Spend Nearly $7,000 on Travel Before Moving In Together, New Mayflower Research Finds
  • imggpt Launches AI-Powered GPT Image Generator and Photo Editor for Creative Teams
  • Intuitive Flow Systems Launches Mokēd Meditation Whistle
  • Styrofoam Recycling Returns to Tacoma Recycle Center
  • More Life Summit 2026 Announces Gary Brecka & Mr. Olympia Derek Lunsford as First Speakers for Miami Event
  • Michael H. Kaplan, Colorado Workers' Compensation Attorney, Rallies Athlete Unions Against Proposed Legislative "Carve-Outs"
  • Viasat, Galaxy 1 Communications and L2 Aviation to bring avionics integration to Advanced Air Mobility
  • Tacoma: OMWBE Intro to Certification 101 Workshop on May 18
  • Spokane Police arrest male for threats against "The Villages" and Mar-A-Lago
  • Fulton County DA Fani Willis Officially Endorses Dr. Heavenly Kimes + Black Economic Agenda
  • AI-Branding Podcast Launches Season 2 Featuring AI Thought Leader on Search Strategy
  • Applicants Sought for the Tacoma Area Commission on Disabilities
_catLbl0 _catLbl1

Popular on Washingtoner

  • Mensa Brings National Board Game Competition to Northern Virginia April 16-19 - 114
  • Tacoma: Lincoln Avenue Bridge to Close Saturday, April 18 for Asphalt Repairs
  • City Council to Discuss ‘Connect Tacoma’ Transportation Levy Replacement at April 14 Study Session
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • Permian Museum Adds Photos of Fossils Discovered on a Meteorite
  • Tacoma Police Department’s CALEA Public Comment Portal
  • Su Che Publishing Announces New Children's Book Celebrating Vaisakhi Festival
  • Cinder Labs Launches AIRA Shield: Purpose-Built AI Security Platform to Combat Shadow AI
  • This Saturday: Open House for Manalapan's Newest Single Family Home Community
  • MainConcept Announces Multiview Encoding for Apple Immersive Video

Similar on Washingtoner

  • 5,521 College Athletes Launch Own Merch Stores in Just 30 Days on AthleteMerch.com, Reaching 7,975 Live Storefronts Nationwide
  • Free Critical Illness Claim Calculator Launches to the Public
  • HRC Fertility Celebrates Beverly Hills Grand Opening, Spotlighting Fertility Care as Women's Health Month Begins
  • HRC Fertility's Dr. Christo G. Zouves Appointed to San Mateo County Medical Association Board of Directors
  • HealthBook+ and Stonebrook Risk Solutions Partner to Bring Predictive Intelligence to Healthcare Risk
  • CCHR: 'Plant-Based' Psychedelics Push Masks Synthetic Drugs and Billion-Dollar Profits
  • L.A. Watts Summer Games Announces Free Pelé Tribute Event at Magic Johnson Park
  • NRx Pharmaceuticals (N A S D A Q: NRXP) Accelerates Into National Spotlight as Manufacturing Launch, Federal Policy & AI-Driven Breakthroughs Converge
  • Intuitive Flow Systems Launches Mokēd Meditation Whistle
  • More Life Summit 2026 Announces Gary Brecka & Mr. Olympia Derek Lunsford as First Speakers for Miami Event
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute